Advertisement
Home 2016

Archives

The proposed capping of copays will raise premiums and is likely to increase drug prices

Capping Copays Will Raise Premiums, Up Drug Prices

0
Capping likely to benefit about 1 percent of all Americans who take any prescription drug per year
The first automated insulin delivery device for type 1 diabetes has been approved by the U.S. Food and Drug Administration for patients aged 14 and older.

FDA Approves ‘Artificial Pancreas’ for Type 1 Diabetes

0
MiniMed 670G hybrid closed loop system automatically monitors glucose, delivers insulin
Empathetic listening can help physicians navigate difficult situations and forge deeper connections with patients

AMA: Practicing Empathy May Lead to More Joy in Medicine

0
Doctors should take advantage of first few minutes of clinical encounter, give full attention to patients
When caring for a child with a concussion

Parents Lack Info on Current Practices for Concussion Recovery

0
Once-recommended practices such as waking a sleeping child for periodic checks can delay healing
Exondys 51 (eteplirsen) injection has been approved by the U.S. Food and Drug Administration for certain patients with Duchenne muscular dystrophy. It is the first drug to gain FDA approval for the condition.

FDA Approves First Drug for Duchenne Muscular Dystrophy

0
Exondys 51 sanctioned for patients with mutation of the dystrophin gene amenable to exon 51 skipping
A device that uses a small balloon to treat Eustachian tube dysfunction has been approved by the U.S. Food and Drug Administration.

FDA Approves Balloon Device for Eustachian Tube Dysfunction

0
Designed to relieve pressure, pain, or clogged or muffled sensations occuring in the ear
Fewer Americans are dying from chronic obstructive pulmonary disease

CDC: COPD-Related Mortality Mostly Down in the United States

0
However, rates are up for black women and middle-aged patients
A combination of fluticasone furoate and vilanterol reduces the rate of moderate or severe exacerbations among patients with chronic obstructive pulmonary disease

Fluticasone Furoate/Vilanterol Cuts Exacerbations in COPD

0
Drop in rate of moderate or severe exacerbations among patients with exacerbation in year before trial
The American Academy of Family Physicians has graded the recommendation for colorectal cancer screening as a B recommendation

AAFP Downgrades USPSTF CRC Screening Recommendation

0
AAFP recommends fecal immunochemical tests, flexible sigmoidoscopy, colonoscopy
A new biological drug to treat rheumatoid arthritis and other inflammatory diseases has been approved by the U.S. Food and Drug Administration.

FDA Approves Biosimilar Drug Erelzi for Rheumatoid Arthritis

0
Erelzi is a biosimilar for Enbrel; treats RA and other inflammatory diseases